BackgroundCheck.run
Search For

Daniel Goldberg, 38930 Tabor Cir, Camarillo, CA 93010

Related to:
Joan P Goldberg 93 Marc D Goldberg 71 Lindsey A Austin 37 Stephanie V Krieger 42

Daniel Goldberg Phones & Addresses

930 Tabor Cir, Camarillo, CA 93010   

Seattle, WA   

1855 Pericles Pl, Oxnard, CA 93033    805-7661428   

Get Report
Control this profile

Mentions for Daniel Goldberg

Career records & work history

Lawyers & Attorneys

Daniel Goldberg Photo 1

Daniel Marc Goldberg, Woodland Hills CA - Lawyer

Address:
Bryan Cave
21700 Oxnard St Ste 430, Woodland Hills, CA 91367
818-8882220 (Office)
Licenses:
California - Active 2011
Education:
University of Southern California Law School
University of California - Los Angeles
Specialties:
Commercial - 40%
Intellectual Property - 40%
Unknown - 20%
Description:
Daniel M. Goldberg is an attorney at Glass Goldberg, a Law Corporation. Daniel focuses his practice on commercial finance and intellectual property matters...
Daniel Goldberg Photo 2

Daniel S Goldberg - Lawyer

Address:
Telesat
613-7480123 (Office)
Licenses:
Dist. of Columbia - Active 1994
Daniel Goldberg Photo 3

Daniel Mark Goldberg - Lawyer

Licenses:
Virginia - Authorized to practice law 2004
Daniel Goldberg Photo 4

Daniel Steven Goldberg - Lawyer

Licenses:
Virginia - Authorized to practice law 1991
Daniel Goldberg Photo 5

Daniel Goldberg - Lawyer

Office:
White Goss Bowers March Schulte & Weisenfels a Professional Corporation
Specialties:
Commercial Litigation, Employment Law, Land Use / Zoning, Construction / Development, Criminal Defense
ISLN:
916435088
Admitted:
2001
University:
University of Kansas, B.A., 1998
Law School:
DePaul College of Law, J.D., 2001
Daniel Goldberg Photo 6

Daniel Goldberg - Lawyer

Specialties:
Environmental & Land Use Law, City, County & Local Govt Law
ISLN:
1000318588
Admitted:
2011
Law School:
University of Miami School of Law, Doctor of Jurisprudence/Juris Doctor, 2011
Daniel Goldberg Photo 7

Daniel Goldberg - Lawyer

Office:
Daniel L. Goldberg
ISLN:
907034122
Admitted:
1985
University:
Pennsylvania State University, B.S., 1982
Law School:
University of Pittsburgh, J.D., 1985
Daniel Goldberg Photo 8

Daniel Goldberg - Lawyer

Office:
Ruberto, Israel & Weiner, P.C.
Specialties:
Real Estate, Litigation, Construction Law, Alternative Dispute Resolution
ISLN:
907034160
Admitted:
1987
University:
College of William & Mary, B.A., 1981
Law School:
Suffolk University Law School, J.D., 1986

Medicine Doctors

Daniel J. Goldberg

Specialties:
Cardiovascular Disease
Work:
Cardiac Associates
15225 Shady Grv Rd STE 201, Rockville, MD 20850
301-6703000 (phone) 301-9240186 (fax)
Site
Cardiac Associates
19735 Germantown Rd STE 190, Germantown, MD 20874
240-4491100 (phone) 240-4491150 (fax)
Site
Education:
Medical School
New York Medical College
Graduated: 1976
Procedures:
Cardiac Stress Test, Angioplasty, Cardioversion, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG), Pacemaker and Defibrillator Procedures
Conditions:
Acute Myocardial Infarction (AMI), Aortic Regurgitation, Aortic Valvular Disease, Cardiac Arrhythmia, Cardiomyopathy, Conduction Disorders, Paroxysmal Supreventricular Tachycardia (PSVT), Pericardidtis, Valvular Heart Disease, Angina Pectoris, Aortic Stenosis, Atrial Fibrillation and Atrial Flutter, Carditis, Congenital Anomalies of the Heart, Endocarditis, Heart Failure, Ischemic Heart Disease, Mitral Regurgitation, Mitral Stenosis, Mitral Valvular Disease
Languages:
Chinese, English, Spanish
Description:
Dr. Goldberg graduated from the New York Medical College in 1976. He works in Rockville, MD and 1 other location and specializes in Cardiovascular Disease. Dr. Goldberg is affiliated with Adventist Healthcare Shady Grove Medical Center, Frederick Memorial Hospital, Laurel Regional Hospital, Medstar Montgomery Medical Center and Washington Adventist Hospital.

Daniel E. Goldberg

Specialties:
Ophthalmology
Work:
Atlantic Eye Physicians
180 White Rd STE 202, Little Silver, NJ 07739
732-2227373 (phone) 732-2199557 (fax)
Site
New York Eye Institute
75 Crystal Run Rd STE 102, Middletown, NY 10941
845-6927066 (phone) 845-6925256 (fax)
Education:
Medical School
SUNY Downstate Medical Center College of Medicine
Graduated: 1974
Languages:
Arabic, English, Spanish
Description:
Dr. Goldberg graduated from the SUNY Downstate Medical Center College of Medicine in 1974. He works in Little Silver, NJ and 1 other location and specializes in Ophthalmology. Dr. Goldberg is affiliated with Good Samaritan Regional Medical Center and Monmouth Medical Center.
Daniel Goldberg Photo 9

Daniel A Goldberg

Specialties:
Psychiatry
Education:
State University of New York at Buffalo (1960)

License Records

Daniel A Goldberg

Licenses:
License #: 120030 - Active
Issued Date: Nov 2, 2016
Expiration Date: Oct 1, 2018
Type: Licensed Independent Clinical Social Worker

Daniel J Goldberg

Licenses:
License #: 28RI01733300 - Expired
Category: Pharmacy
Issued Date: Jan 7, 1983
Type: Pharmacist

Daniel J Goldberg

Licenses:
License #: 28RI01733300 - Expired
Category: Pharmacy
Issued Date: Jan 7, 1983
Type: Pharmacist

Publications & IP owners

Us Patents

Spirocyclic Compounds As Tryptophan Hydroxylase Inhibitors

US Patent:
2021020, Jul 8, 2021
Filed:
Mar 15, 2021
Appl. No.:
17/201750
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Kenneth Brameld - Menlo Park CA, US
Eric Brian Sjogren - Mountain View CA, US
Andrew Scribner - Durham NC, US
Assignee:
Altavant Sciences GmbH - Basel
International Classification:
A61K 31/506
C07D 471/10
C07D 519/00
A61K 9/00
Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Processes For Preparing Tph1 Inhibitors

US Patent:
2021013, May 13, 2021
Filed:
Jan 14, 2021
Appl. No.:
17/149070
Inventors:
- BASEL, CH
DANIEL R. GOLDBERG - SEATTLE WA, US
Assignee:
ALTAVANT SCIENCES GmbH - BASEL
International Classification:
C07D 471/10
Abstract:
The present disclosure is directed to intermediates and salts thereof useful for the preparation of spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1). Processes of preparing the intermediates, salts, and TPH inhibitors are also provided.

Spirocyclic Compounds As Tryptophan Hydroxylase Inhibitors

US Patent:
2020023, Jul 30, 2020
Filed:
Apr 16, 2020
Appl. No.:
16/850542
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Kenneth Brameld - Menlo Park CA, US
Eric Brian Sjogren - Mountain View CA, US
Andrew Scribner - Durham NC, US
Assignee:
Roivant Sciences GmbH - Basel
International Classification:
A61K 31/506
A61K 9/00
C07D 471/10
C07D 519/00
Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Processes For Preparing (R)-1-(5-Chloro-[1,1'-Biphenyl]-2-Yl)-2,2,2-Trifluoroethanol And 1-(5- Chloro-[1,1'-Biphenyl]-2-Yl)-2,2,2-Trifluoroethanone

US Patent:
2019037, Dec 12, 2019
Filed:
Aug 21, 2019
Appl. No.:
16/546906
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Assignee:
Roivant Sciences GmbH - Basel
International Classification:
C07C 29/32
C07C 29/143
C07C 259/10
C07C 45/45
C07C 49/80
Abstract:
The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.

Spirocyclic Compounds As Tryptophan Hydroxylase Inhibitors

US Patent:
2019028, Sep 19, 2019
Filed:
May 30, 2019
Appl. No.:
16/426698
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Kenneth Brameld - Menlo Park CA, US
Eric Brian Sjogren - Mountain View CA, US
Andrew Scribner - Durham NC, US
Assignee:
Altavant Sciences GmbH - Basel
International Classification:
A61K 31/506
C07D 519/00
A61K 9/00
C07D 471/10
Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Processes For Preparing Tph1 Inhibitors

US Patent:
2019026, Aug 29, 2019
Filed:
May 9, 2019
Appl. No.:
16/407375
Inventors:
- Basel, CH
DANIEL R. GOLDBERG - Seattle WA, US
Assignee:
ALTAVANT SCIENCES GmbH - Basel
International Classification:
C07D 471/10
Abstract:
The present disclosure is directed to intermediates and salts thereof useful for the preparation of spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH 1). Processes of preparing the intermediates, salts, and TPH inhibitors are also provided.

Spirocyclic Compounds As Tryptophan Hydroxylase Inhibitors

US Patent:
2018025, Sep 13, 2018
Filed:
May 14, 2018
Appl. No.:
15/978361
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Kenneth Brameld - Menlo Park CA, US
Eric Brian Sjogren - Mountain View CA, US
Andrew Scribner - Durham NC, US
International Classification:
A61K 31/506
A61K 9/00
Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Spirocyclic Compounds As Tryptophan Hydroxylase Inhibitors

US Patent:
2018009, Apr 5, 2018
Filed:
Jul 10, 2017
Appl. No.:
15/645054
Inventors:
- Basel, CH
Daniel R. Goldberg - Seattle WA, US
Kenneth Brameld - Menlo Park CA, US
Eric Brian Sjogren - Mountain View CA, US
Andrew Scribner - Durham NC, US
International Classification:
A61K 31/506
A61K 9/00
Abstract:
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Isbn (Books And Publications)

Texas Collections Manual: A Project Of The Professional Efficiency And Economic Research Committee Of The State Bar Of Texas

Author:
Daniel J. Goldberg
ISBN #:
0938160451

Contemporary Marriage: Special Issues In Couples Therapy

Author:
Daniel C. Goldberg
ISBN #:
0256034842

Contemporary Marriage: Special Issues In Couples Therapy

Author:
Daniel C. Goldberg
ISBN #:
0534112595

Possible Relatives

David R Goldberg  Dean G Goldberg  Deanna Goldberg  Dale Goldberg  Deborah R Goldberg  Deidre E Goldberg  Dena Goldberg  Daniel G Last  Daniel J Johnson  Daniel W Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.